Journal of Korean Neurosurgical Society

  • 제47권1호
  • /
  • Pages.30-35
  • /
  • 2010
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

The Effects of TWEAK, Fn14, and TGF-$\beta1$ on Degeneration of Human Intervertebral Disc

  • Huh, Hoon (Department of Neurosurgery, Medical Institute, Seoul Medical Center) ;
  • Lee, Yong-Jik (Division of Clinical Research, Medical Institute, Seoul Medical Center) ;
  • Kim, Jung-Hee (Department of Neurosurgery, Medical Institute, Seoul Medical Center) ;
  • Kong, Min-Ho (Department of Neurosurgery, Medical Institute, Seoul Medical Center) ;
  • Song, Kwan-Young (Department of Neurosurgery, Medical Institute, Seoul Medical Center) ;
  • Choi, Gun (Clinical Division of Spine, Wooridul Spine Hospital)
  • 발행 : 2010.01.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The purpose of this study is to explain the effect and reciprocal action among tumor necrosis factor (TNF) like weak inducer of apoptosis (TWEAK), fibroblast growth factor-inducible 14 (Fn14), and transforming growth factor-$\beta1$ (TGF-$\beta1$) on degeneration of human intervertebral disc (IVD). Methods: Human intervertebral disc tissues and cells were cultured with Dulbecco's Modified Eagle's Medium/Nutrient F-12 Ham (DMEM/F-12) media in $37^{\circ}C$, 5% $CO_2$ incubator. When IVD tissues were cultured with TWEAK, Fn14 that is an antagonistic receptor for TWEAK and TGF-$\beta1$, the level of sulfated glycosaminoglycan (sGAG) was estimated by dimethyl methyleneblue (DMMB) assay and sex determining region Y (SRY)-box 9 (Sox9) and versican messenger ribonucleic acid (mRNA) levels were estimated by reverse transcriptase polymerase chain reaction (RT-PCR). Results: When human IVD tissue was cultured for nine days, the sGAG content was elevated in proportion to culture duration. The sGAG was decreased significantly by TWEAK 100 ng/mL, however, Fn14 500 ng/mL did not change the sGAG production of IVD tissue. The Fn14 increased versican and Sox9 mRNA levels decreased with TWEAK in IVD tissue TGF-$\beta1$ 20 ng/mL elevated the sGAG concentration 40% more than control. The sGAG amount decreased with TWEAK was increased with Fn14 or TGF-$\beta1$ but the result was insignificant statistically. TGF-$\beta1$ increased the Sox9 mRNA expression to 180% compared to control group in IVD tissue. Sox9 and versican mRNA levels decreased by TWEAK were increased with TGF-$\beta1$ in primary cultured IVD cells, however, Fn14 did not show increasing effect on Sox9 and versican. Conclusion: This study suggests that TWEAK would act a role in intervertebral disc degeneration through decreasing sGAG and the mRNA level of versican and Sox9.

키워드

참고문헌

  1. Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, et al. : TWEAK/Fn14 interaction regulated RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 8 : R146, 2006 https://doi.org/10.1186/ar2038
  2. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, et al. : TWEAK, a new scereted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272 : 32401-32410, 1997 https://doi.org/10.1074/jbc.272.51.32401
  3. Deyo RA : Back surgery-who needs it? N Engl J Med 356 : 2239-2243, 2007 https://doi.org/10.1056/NEJMp078052
  4. Farndale RW, Buttle DJ, Barrett AJ : Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883 : 173-177, 1986 https://doi.org/10.1016/0304-4165(86)90306-5
  5. Gruber HE, Norton HJ, Ingram JA, Hanley EN Jr : The Sox9 transcription factor in the human disc : decreased immunolocalization with age and disc degeneration. Spine 30 : 625-630, 2005 https://doi.org/10.1097/01.brs.0000155420.01444.c6
  6. Haro H, Crawford HC, Fingleton B, MacDougall JR, Shinomiya K, Spengler DM, et al. : Matrix metalloproteinase-3- dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest 105 : 133-141, 2000 https://doi.org/10.1172/JCI7090
  7. Kwawakami Y, Rodriguez-Leon J, Belmonte JC : The role of TGF-$\beta$s and Sox9 during limb chondrogenesis. Curr Opin Cell Bio 18 : 723-729, 2006 https://doi.org/10.1016/j.ceb.2006.10.007
  8. Kuh SU, Zhu Y, Li J, Tsai KJ, Fei Q, Hutton WC, et al. : Can TGF- $\beta$1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells? Acta Neurochir (Wien) 150 : 1073-1079; discussion 1079, 2008 https://doi.org/10.1007/s00701-008-0029-z
  9. Le Maitre CL, Freemont AJ, Hoyland JA : A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol 87 : 17-28, 2006 https://doi.org/10.1111/j.0959-9673.2006.00449.x
  10. Le Maitre CL, Hoyland JA, Freemont AJ : Degeneration of intervertebral discs : current understanding of cellular and molecular events, and implications for novel therapies. Expert Rev Mol Med 29 : 1-10, 2001
  11. Le Maitre CL, Hoyland JA, Freemont AJ : Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc : an in situ-zymographic and gene therapy study. Arthritis Res Ther 9 : R83, 2007 https://doi.org/10.1186/ar2282
  12. Le Maitre CL, Hoyland JA, Freemont AJ : The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7 : R732- R745, 2005 https://doi.org/10.1186/ar1732
  13. Lee YJ, Kong MH, Song KY, Lee KH, Heo SH : The relation between SOX 9, TGF $\beta$1 and proteoglycan in human intervertebral disc cells. J Korean Neurosurg Soc 43 : 149-154, 2008 https://doi.org/10.3340/jkns.2008.43.3.149
  14. Li J, Yoon ST, Hutton WC : Effect of bone morphogenetic protein- 2(BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells. J Spinal Disord Tech 17 : 423-428, 2004 https://doi.org/10.1097/01.bsd.0000112084.85112.5d
  15. Martin MD, Boxell M, Malone DG : Pathophysiology of lumbar disc degeneration : a review of the literature. Neurosurg Focus 13 : E1, 2002
  16. Okargly A, Balwit JM, Haak-Frendscho M : Transforming Growth Factor beta-1 (TGF-beta-1) : a biological paradox. Promega Notes 47 : 10, 1994
  17. Perper SJ, Browning B, Burkly LC, Weng S, Gao C, Giza K, et al. : TWEAK is a novel arthritogenic mediator. J Immunol 177 : 2610-2620, 2006
  18. Podichetty VK : The aging spine : the role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol 53 : 4-18, 2007
  19. Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand AS, Vaccaro Ar, et al. : Differentiation of Mesenchymal Stem Cells towards a nucleus pulposus-like phenotype in vitro : implications for cell based transplantation therapy. Spine 29 : 2627-2632, 2004 https://doi.org/10.1097/01.brs.0000146462.92171.7f
  20. Stevens AL, Wheeler CA, Tannenbaum SR, Grodzinsky AJ : Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants. Osteoarthritis Cartilage 16 : 489-497, 2008 https://doi.org/10.1016/j.joca.2007.07.015
  21. Wako M, Haro H, Ando T, Hatsushika K, Ohba T, Iwabuchi S, et al. : Novel function of TWEAK in inducing intervertebral disc degeneration. J Orthop Res 25 : 1438-1446, 2007 https://doi.org/10.1002/jor.20445

피인용 문헌

  1. Cell differentiation modeled via a coupled two-switch regulatory network vol.20, pp.4, 2010, https://doi.org/10.1063/1.3505000
  2. BMP7-Based Functionalized Self-Assembling Peptides for Nucleus Pulposus Tissue Engineering vol.7, pp.31, 2010, https://doi.org/10.1021/acsami.5b03605
  3. Downregulated microRNA‐330 suppresses left ventricular remodeling via the TGF‐β1/Smad3 signaling pathway by targeting SRY in mice with myocardial ischemia–reperfusion injury vol.234, pp.7, 2010, https://doi.org/10.1002/jcp.27800